| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share | 1,482,844 | $6,020,347 | $4.06 | 22 Oct 2024 | Held through Knight Therapeutics International SA, a subsidiary of Knight Therapeutics Inc. | ||
| Pre-Funded Common Stock Purchase Warrant | 428,570 | 11 Jun 2025 | Indirect | Common Stock |
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|